Mode
Text Size
Log in / Sign up
N/A N=12 Treatment

The Effect of HIT in Patients With Non-alcoholic Fatty Liver Disease/Steatohepatitis

Non-alcoholic Steatohepatitis · Non-alcoholic Fatty Liver Disease

Enrolled (actual)
12
Serious AEs
8.3%
Results posted
May 2018
Primary outcome: Primary: Homeostasis Model Assessment of Insulin Resistance (HOMA-IR) — 6.9; 9.6; 7.0 units on a scale — p=0.474

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
High-intensity Interval Training (Other)
Age
Adult · 20+ yrs
Sex
All
Sponsor
University of Bath
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Homeostasis Model Assessment of Insulin Resistance (HOMA-IR)
6.9; 9.6; 7.0 0.474
PRIMARY
Oral Glucose Tolerance Test
981; 1030; 1010 0.174
PRIMARY
AST: ALT Ratio
0.5; 0.5; 0.5 0.303
PRIMARY
FIB-4
0.68; 0.60; 0.60 0.023 sig
PRIMARY
Body Fat Mass Estimated Via Bioimpedance
29.7; 29.5; 28.3; 26.6; 29.1; 28.6 0.092
PRIMARY
Blood Pressure
139; 142; 136; 85; 87; 78 0.771
PRIMARY
General Well-being as Assessed by SF-36 Questionnaire
79; 85; 92; 78; 82; 83 0.099
PRIMARY
Short-term Memory Recall
6; 7; 6 0.310
PRIMARY
Estimated VO2 Max
34.9; 37.6; 38.5 <0.001 sig
PRIMARY
Physical Function-"Get up and go" Test
6.61; 6.23; 5.87 0.005 sig
PRIMARY
Ankle Brachial Pressure Index (ABPI)
1.15; 1.08; 1.13 0.793
PRIMARY
Long-term Memory Recall
4; 5; 5 0.513
PRIMARY
Executive Function (Verbal Fluency Test)
8; 12; 11 0.009 sig

Summary

This pilot study aims to investigate whether 6 weeks of twice weekly High-intensity Interval Training (HIT) results in improvements in disease-specific measures, feelings of general well-being, physical fitness and cognitive function in patients with non-alcoholic fatty liver disease or non-alcoholic steatohepatitis.

Eligibility Criteria

Inclusion Criteria

  • clinical diagnosis of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis
  • attending a specialist liver clinic at Ninewells Hospital, Dundee

Exclusion Criteria

  • unstable cardiovascular disease
  • uncontrolled arrhythmias
  • structural cardiac abnormalities
  • uncontrolled diabetes
  • other uncontrolled metabolic abnormalities
  • severe orthopaedic condition that would prohibit exercise
  • severe pulmonary condition that would prohibit exercise
  • any other poorly controlled medical condition.
  • resting systolic blood pressure above 160 mm Hg
  • resting diastolic blood pressure above 90 mm Hg
  • symptomatic postural drop in blood pressure greater than 20 mm Hg
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02528305). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search